Non-inferior study of balanced salt solution versus human albumin solution in reversing end-stage liver disease be complicated of acute kidney injury

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000034544

Enrollment

Unknown

Registered

2020-07-09

Start date

2020-07-06

Completion date

Unknown

Last updated

2020-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acute kidney injury

Interventions

Group 1:balance solution

Group 2:human albumin solution

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Adult patients with end-stage liver disease (aged >= 18 years): 2. Refers to the late stage of liver disease caused by various liver damage. 3. It includes liver cirrhosis, liver failure and liver cancer caused by various reasons in adult patients, among which liver failure mainly involves acute, subacute, acute on chronic liver failure.

Exclusion criteria

Exclusion criteria: 1. Aged < 18 years; 2. kidney or liver transplantation; 3. Pregnant or lactating; 4. Acute or chronic heart failure; 5. Allergic to human serum albumin; 6. Contrast induced nephropathy; 7. Drug induced renal injury was suspected or confirmed; 8. It is suspected that renal organic disease is caused; 9. Urinary tract obstruction; 10. Patients or their families refused to sign informed consent.

Design outcomes

Primary

Measure	Time frame
Renal function reverse rate on day 7;	—

Secondary

Measure	Time frame
survival of 28 day;	—

Countries

China

Contacts

Public ContactLiu Songtao

botao8080@163.com+86 13811120755

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026